HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Cp-547632

HCID 9811611
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
252003-65-9
Standard SMILES
NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1
InChIKey
HXHAJRMTJXHJJZ-UHFFFAOYSA-N
Molecular formula
C20H24BrF2N5O3S
Average molar mass
532.4 g/mol
Monoisotopic mass
531.07513

Overview

CP-547632 has been used in trials studying the treatment of Ovarian Cancer, Lung Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, and Fallopian Tube Cancer, among others.

Names & identifiers

Preferred name
Cp-547632
IUPAC
3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide
English name
CP-547632
Molecular formula
C20H24BrF2N5O3S
Molecular weight
532.4

Names & synonyms

252003-65-9CP-547632CP 547632CP-547,632OSI-632W1B375O5M2CP 547,632PAN 908063-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamideCP547632DTXSID00179866PAN90806
Show more names
CS-1957CP-547632(CP 547632)CP-547632 (PAN-90806)CP-547632, 10 mM in DMSO3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carbox3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxami3-[(4-Bromo-2,6-difluorobenzyl)oxy]-5-[3-[4-(pyrrolidin-1-yl)butyl]ureido]isothiazole-4-carboxamide3-(4-Bromo-2,6-difluorobenzyloxy)-5-(3-(4-pyrrolidin-1-ylbutyl)ureido)isothiazole-4-carboxylic acid amide
CP-632PAN-908064-Isothiazolecarboxamide, 3-((4-bromo-2,6-difluorophenyl)methoxy)-5-((((4-(1-pyrrolidinyl)butyl)amino)carbonyl)amino)-4-Isothiazolecarboxamide, 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-3-((4-bromo-2,6-difluorophenyl)methoxy)-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamideRefChem:919128DTXCID60102357CP547,632

Properties

Computed structural propertiesFilling in

XLogP
3.7
Topological polar surface area
138 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
8
Rotatable bonds
10
Heavy atoms
32
Formal charge
0
Complexity
622

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
548.6 · 548.6±50.0 °C(Predicted)
Density
1.532 · 1.532
storage temp.
2 · 2-8°C
solubility
94 mM · DMSO: 94 mM
form
A solid
pka
12.5 · 12.50±0.70(Predicted)
color
White to light yellow
InChIKey
HXHAJRMTJXHJJZ-UHFFFAOYSA-N
SMILES
S1C(NC(NCCCCN2CCCC2)=O)=C(C(N)=O)C(OCC2=C(F)C=C(Br)C=C2F)=N1
NCI Dictionary of Cancer Terms
-547 · CP-547; 632
FDA UNII
1 B375O5M2 · W1B375O5M2
Symbol(GHS)
7 · GHS07

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H320-H335
Precautionary statements
P264-P270-P301+P312-P330

Chemistry & industry

Applications · 2 items

DescriptionCP 547,632 is an orally bioavailable and potent inhibitor of the receptor tyrosine kinases VEGF receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) with IC50 values of 11 and 9 nM, respectively, in an enzyme assay. It is selective for VEGFR2 and bFGF over EGFR, PDGF receptor β (PDGFRβ), and related tyrosine kinases. CP 547,632 inhibits VEGFR2 autophosphorylation induced by VEGF in porcine aortic endothelial cells transfected with VEGFR2 (IC50 = 6 nM) and in a xenograft mouse model using NIH3T3/H-Ras cells (EC50 = 590 nM). It decreases angiogenesis induced by VEGF or bFGF and suppresses tumor growth in athymic mice.

UsesCP-547632 is an orally active, ATP-competitive and potent VEGFR-2 and FGF kinases inhibitor with IC50s of 11 nM and 9 nM, respectively. CP-547632 is selective for VEGFR2 and bFGF over EGFR, PDGFRβ, and related tyrosine kinases (TKs). CP-547632 has antitumor efficacy[1].

Upstream & downstream products

Downstream products

CP-547632 (hydrochloride)

Related reactions

7 records
New reaction record
HRID 335521 reaction equation
HRID 335521As product
HRID 750597 reaction equation
HRID 750597As product
HRID 1266388 reaction equation
HRID 1266388As product
HRID 1712153 reaction equation
HRID 1712153As product
HRID 1977873 reaction equation
HRID 1977873As product
HRID 2150143 reaction equation
HRID 2150143As product
HRID 2205434 reaction equation
HRID 2205434As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
252003-65-9
PubChem CID
9811611
DTXSID
DTXSID00179866
ChEMBL
CHEMBL253969
UNII
W1B375O5M2
Signal word
Warning
Hazard statements
302 · H302-H315-H320-H335
Precautionary statements
264 · P264-P270-P301+P312-P330